Filter Results:
(557)
Show Results For
- All HBS Web
(557)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(557)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug View Details
- 25 Aug 2014
- News
Wendell P. Weeks, MBA 1987
brink of failure through a painful restructuring and commitment to both innovation and the diversification of its product lines. “We make products that change the world,” he says, noting Corning’s development of LCD glass; tools to... View Details
Keywords: Susan Young
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A pioneer in the View Details
- 01 Feb 2000
- News
Bart Harvey: Opportunities for Others
even as he enjoyed a successful career as a high-flying real-estate dealmaker at Dean Witter Reynolds. Then he was introduced to the late James Rouse, the visionary developer who founded the Enterprise Foundation in 1982. "Jim Rouse... View Details
- Profile
Arjun Goyal
a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
companies feared that the precedent set by the South African move would undermine their control over valuable intellectual property in the developing world. But the suit sparked international outrage against the industry, prompting a very... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- Web
Market Perspectives - Course Catalog
cases explore concrete situations that highlight the challenges and tradeoffs of decision-makers. Issues explored include: education, urban development, illegal drugs, rent control, housing, drug pricing, racial references, corporate... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill costs 5 cents to manufacture,... View Details
Keywords: by Max H. Bazerman
- Portrait Project
Sarah Assayag
I would become the first colony settler on Earth 2.0, develop drugs that would allow humans to become immortal, and create an android that would fall asleep by counting electric sheep. My 8-year-old self,... View Details
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- 19 Oct 2023
- Blog Post
New Venture Competition 2023: Business and Environment Ventures
entrants, and we wanted to highlight the contestants from this year’s competition who are developing a wide range of ventures to address climate change. WINNER: Tough Tech: Most Promising Climate Tech Venture $5,000 Prize Grensol - Rajiv... View Details
- 30 Mar 2010
- First Look
First Look: March 30
GordonHarvard Business School Case 810-066 In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic... View Details
Keywords: Sean Silverthorne
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
Hansjörg Wyss (MBA 1965) has been unusually public of late, celebrated for his visionary accomplishments in health care and conservation. Wyss, 75, founded Synthes USA, a Swiss-American firm, in 1974 and led it to global prominence as a pioneer in the View Details
- 27 Nov 2017
- Research & Ideas
Beware the Lasting Impression of a 'Temporary' Selfie
a prop, or exhibited nudity, drinking, or drug use. As to the impact on observers of the posts, the temporary-sharers were characterized as having worse judgment than those who shared in permanent mediums. That belief was underscored... View Details
Keywords: by Rachel Layne
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
but his choice was driven by the School’s mission to develop leaders who contribute to the well-being of society. “HBS has given me an expanded sense of perspective and of what is attainable,” says Moret, who recently completed a field... View Details
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
forecasting expected revenues, to developing an equity investing plan for a major pharmaceutical company and performing due diligence on M&A targets. I also spent four months on secondment within a pharma company's Commercial Oncology... View Details
- Web
Finalists | New Venture Competition
Finalists Business Track, 2025 Accio Alex Zannos (MBA 2025) Sara Ballantyne (MS/MBA 2025) Streamline and automates the hardware manufacturing process. Argus Systems Lisa Yan (MBA 2025) Drew Borinstein (MBA 2025) Accelerating AI model View Details
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
difficult and time-consuming even in countries with sufficient medical resources, much less in developing countries where the need is great but fewer personnel have the time and training. Harvard researchers wondered: Could programmers... View Details
- Student-Profile
A Jay Holmgren
A Jay Holmgren (he/him) hadn’t yet developed a strong interest in health policy when he graduated from the University of Michigan with a BA in History in 2011. But when his father was diagnosed with cancer in 2014, A Jay found himself... View Details